ICICI Securities recommended reduce rating on GlaxoSmithKline Pharmaceuticals with a target price of Rs 2,600 in its research ...

GlaxoSmithKline (GSK) has announced the repurchase of 783,700 of its ordinary shares as part of its ongoing buyback program, executed through Citigroup Global Markets Limited. This transaction is part ...

Decision follows underwhelming Phase II results from GALAXIES Lung-201 and H&N-202 trials, prompting iTeos and GSK to end ...

May 13 (Reuters) - India's GlaxoSmithKline Pharmaceuticals ... The Indian unit of British drugmaker GSK (GSK.L), opens new tab reported consolidated profit of 2.63 billion rupees ($30.86 million ...

GSK Pharma reports 35 per cent YoY rise in Q4FY25 profit led by gains in general medicines and vaccines; oncology launches ...

Investors might want to bet on GSK (GSK), as it has been recently upgraded ... As such, the Zacks rating upgrade for Glaxo is essentially a positive comment on its earnings outlook that could ...